(Q34046556)

30 July 2017

title

Survival endpoints in colorectal cancer and the effect of second primary other cancer on disease free survival (English)

1 reference

30 July 2017

1 reference

1 reference

4

Bengt Glimelius

1 reference

30 July 2017

Helgi Birgisson

1

1 reference

30 July 2017

Ulrik Wallin

series ordinal

2

1 reference

30 July 2017

Lars Holmberg

series ordinal

3

1 reference

30 July 2017

language of work or name

English

0 references

publication date

11 October 2011

1 reference

30 July 2017

1 reference

30 July 2017

volume

11

1 reference

30 July 2017

page(s)

438

1 reference

https://scigraph.springernature.com/pub.10.1186/1471-2407-11-438

30 July 2017

exact match

0 references

cites work

Association between disease-free survival and overall survival when survival is prolonged after recurrence in patients receiving cytotoxic adjuvant therapy for colon cancer: simulations based on the 20,800 patient ACCENT data set

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3209454

The completeness of the Swedish Cancer Register: a sample survey for year 1998.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3209454

Disease-free survival versus overall survival as a primary end point for adjuvant colon cancer studies: individual patient data from 20,898 patients on 18 randomized trials

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3209454

The revised CONSORT statement for reporting randomized trials: explanation and elaboration

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3209454

Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3209454

The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials

28 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-438

Survival end point reporting in randomized cancer clinical trials: a review of major journals

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-438

Endpoints in adjuvant treatment trials: a systematic review of the literature in colon cancer and proposed definitions for future trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-438

The Swedish rectal cancer registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-438

Adjuvant Therapy for completely resected Stage II Colon Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-438

The risk of subsequent primary cancers after colorectal cancer in southeast England.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-438

Occurrence of second cancers in patients treated with radiotherapy for rectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-438

Prognostic role of KRAS and BRAF in stage II and III resected colon cancer: results of the translational study on the PETACC-3, EORTC 40993, SAKK 60-00 trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-438

Evidence for cure by adjuvant therapy in colon cancer: observations based on individual patient data from 20,898 patients on 18 randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-438

Clinical trial enrollment, patient characteristics, and survival differences in prospectively registered metastatic colorectal cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-438

The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-438

Clinical features of second other-site primary cancers among sporadic colorectal cancer patients--a hospital-based study of 3,722 cases

21 January 2018

1 reference

12 December 2020

Definition of disease-free survival: this is my truth–show me yours

1 reference

12 December 2020

A population-based analysis of second primary cancers after irradiation for rectal cancer

1 reference

12 December 2020

The correlation between a family history of colorectal cancer and survival of patients with colorectal cancer

1 reference

12 December 2020

Second primary cancer in patients with colorectal cancer after a curative resection

1 reference

12 December 2020

Preoperative plasma TIMP-1 is an independent prognostic indicator in patients with primary colorectal cancer: A prospective validation study

1 reference

12 December 2020

Second primary cancers after sporadic and familial colorectal cancer

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-2407-11-438

1 reference

Dimensions Publication ID

30 July 2017

0 references

1 reference

30 July 2017

1 reference